Ingber et al. [106] stated that fumagillin completely inhibits endothelial cell proliferation in the presence of basic fibroblast growth factor (bFGF), and also inhibits tumor suppressor-induced neovascularization in mice [106]. This evidence concerns the gene FGF2 and neoplasm.